Key statistics
As of last trade Aldeyra Therapeutics Inc (137:FRA) traded at 4.88, -15.75% below its 52-week high of 5.79, set on Sep 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.88 |
---|---|
High | 4.88 |
Low | 4.88 |
Bid | 4.84 |
Offer | 4.94 |
Previous close | 4.70 |
Average volume | 2.02k |
---|---|
Shares outstanding | 59.42m |
Free float | 48.69m |
P/E (TTM) | -- |
Market cap | 317.31m USD |
EPS (TTM) | -0.6387 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 07:20 BST.
More ▼
Press releases
- Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
- Aldeyra Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
- Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 Dry Eye Disease Clinical Trial of Reproxalap
- Aldeyra Therapeutics Schedules Conference Call and Webcast to Announce Top-Line Results from the Phase 3 Dry Eye Chamber Clinical Trial of Reproxalap